Tonix Pharmaceuticals Hol... (TNXP)
NASDAQ: TNXP
· Real-Time Price · USD
40.04
-11.31 (-22.03%)
At close: Aug 18, 2025, 3:59 PM
38.54
-3.75%
Pre-market: Aug 19, 2025, 08:30 AM EDT
Tonix Pharmaceuticals Revenue
Tonix Pharmaceuticals reported an annual revenue of $10.09M, reflecting a 29.94% growth. For the quarter ending June 30, 2025, Tonix Pharmaceuticals generated $2M in revenue.
Revenue (ttm)
10.09M
Revenue Growth
29.94%
Price / Sales Ratio
7.4
Revenue / Employee
124.62K
Employees
81
Market Cap
350.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 10.09M | +29.94% |
Dec 31, 2023 | 7.77M | -13.95% |
Dec 31, 2022 | 9.03M | +Infinity% |
Dec 31, 2021 | 0 | -100.00% |
Dec 31, 2020 | 2.91M | +Infinity% |
Dec 31, 2019 | 0 | n/a |
Dec 31, 2018 | 0 | n/a |
Dec 31, 2017 | 0 | n/a |
Dec 31, 2016 | 0 | n/a |
Dec 31, 2015 | 0 | n/a |
Dec 31, 2014 | 0 | n/a |
Dec 31, 2013 | 0 | n/a |
Dec 31, 2012 | 0 | n/a |
Dec 31, 2011 | 0 | n/a |
Dec 31, 2010 | 0 | n/a |
Dec 31, 2009 | 0 | n/a |
Dec 31, 2008 | 0 | n/a |